ZA987806B - Substituted chroman derivatives - Google Patents

Substituted chroman derivatives

Info

Publication number: ZA987806B
Authority: ZA; South Africa
Prior art keywords: chroman derivatives; substituted chroman; substituted; derivatives; chroman
Prior art date: 1997-09-18

Application number

ZA987806A

Other languages

English (en)

Inventor

Stefan Berg

Mats Linderberg

Svante Ross

Seth-Olov Thorberg

Bengt Ulff

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-18

Filing date

1998-08-27

Publication date

1999-03-18

1998-08-27 Application filed by Astra Ab filed Critical Astra Ab

1999-03-18 Publication of ZA987806B publication Critical patent/ZA987806B/xx

Links

VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

ZA987806A 1997-09-18 1998-08-27 Substituted chroman derivatives ZA987806B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9703378A SE9703378D0 (sv)	1997-09-18	1997-09-18	New compounds

Publications (1)

Publication Number	Publication Date
ZA987806B true ZA987806B (en)	1999-03-18

Family

ID=20408298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA987806A ZA987806B (en)	1997-09-18	1998-08-27	Substituted chroman derivatives

Country Status (23)

Country	Link
US (2)	US6387899B1 (fr)
EP (1)	EP1025096B1 (fr)
JP (1)	JP4002392B2 (fr)
KR (1)	KR20010024078A (fr)
CN (1)	CN1278809A (fr)
AR (1)	AR016651A1 (fr)
AT (1)	ATE255099T1 (fr)
AU (1)	AU9193398A (fr)
BR (1)	BR9812239A (fr)
CA (1)	CA2303926A1 (fr)
DE (1)	DE69820103T2 (fr)
EE (1)	EE200000144A (fr)
HR (1)	HRP20000133A2 (fr)
HU (1)	HUP0100276A3 (fr)
IL (1)	IL135074A0 (fr)
IS (1)	IS5403A (fr)
NO (1)	NO20001403L (fr)
PL (1)	PL339661A1 (fr)
SE (1)	SE9703378D0 (fr)
SK (1)	SK2872000A3 (fr)
TR (1)	TR200000737T2 (fr)
WO (1)	WO1999014213A1 (fr)
ZA (1)	ZA987806B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9703377D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
BR0206513A (pt)	2001-01-16	2004-01-06	Astrazeneca Ab	Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
MXPA03006250A (es)	2001-01-16	2003-09-22	Astrazeneca Ab	Compuestos heterociclicos terapeuticos.
NZ526699A (en) *	2001-01-16	2005-03-24	Astrazeneca Ab	8-amino derivatives and their use in treating migraine
WO2002066454A1 (fr) *	2001-02-21	2002-08-29	Sankyo Company, Limited	Derives de chromene
US7504395B2 (en)	2001-07-20	2009-03-17	Psychogenics, Inc.	Treatment for attention-deficit hyperactivity disorder
GB0124020D0 (en) *	2001-10-05	2001-11-28	Astrazeneca Ab	Chemical compounds
ITTO20030140U1 (it) *	2003-09-16	2005-03-17	Interfila Srl	Matita cosmetica
CA2580584C (fr) *	2003-09-19	2015-07-28	Galileo Pharmaceuticals, Inc.	Utilisation d'alpha-tocotrienol pour le traitement de maladies mitochondriales
US20050165025A1 (en) *	2004-01-22	2005-07-28	Recordati Ireland Ltd.	Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
KR100681453B1 (ko) *	2005-03-22	2007-02-12	태남자동화기기 주식회사	권종 분류 기능을 구비한 지폐 방출기
US9066903B2 (en)	2006-02-28	2015-06-30	The United States Of America As Represented By The Department Of Veterans Affairs	Pharmacological treatment of Parkinson's disease
WO2008130323A1 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux dérivés 8-pipérazine-tétrahydronaphtalène utilisés pour le traitement de la douleur
WO2008130322A1 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux dérivés 5-hétérocyclyl-chromane utilisés pour le traitement de la douleur
SA08290245B1 (ar)	2007-04-23	2012-02-12	استرازينيكا ايه بي	مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
WO2008130321A2 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux composés 807
WO2008130319A2 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux composés 805

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990012795A1 (fr) *	1989-04-27	1990-11-01	The Upjohn Company	3-amino chromanes substitues
US5420151A (en) *	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
SE8904361D0 (sv) *	1989-12-22	1989-12-22	Astra Ab	New chroman and thiochroman derivatives
JPH11511156A (ja)	1995-08-11	1999-09-28	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	ビフェニル（チオ）アミドおよびビフェニルエタン（チオ）オン誘導体、その製造方法ならびに５−ｈｔ▲下１ｄ▼ 受容体拮抗薬としてのその使用

1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 EP EP98944378A patent/EP1025096B1/fr not_active Expired - Lifetime
- 1998-09-09 CA CA002303926A patent/CA2303926A1/fr not_active Abandoned
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Withdrawn
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/xx unknown
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/fr not_active Ceased
- 1998-09-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
2000
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
TR200000737T2 (tr)	2000-09-21
IS5403A (is)	2000-03-14
JP2001516755A (ja)	2001-10-02
HRP20000133A2 (en)	2001-12-31
HUP0100276A3 (en)	2002-08-28
WO1999014213A1 (fr)	1999-03-25
DE69820103D1 (de)	2004-01-08
SK2872000A3 (en)	2000-11-07
NO20001403D0 (no)	2000-03-17
DE69820103T2 (de)	2004-09-02
AR016651A1 (es)	2001-07-25
ATE255099T1 (de)	2003-12-15
IL135074A0 (en)	2001-05-20
CA2303926A1 (fr)	1999-03-25
SE9703378D0 (sv)	1997-09-18
EP1025096B1 (fr)	2003-11-26
US6387899B1 (en)	2002-05-14
CN1278809A (zh)	2001-01-03
NO20001403L (no)	2000-05-18
BR9812239A (pt)	2000-07-18
PL339661A1 (en)	2001-01-02
HUP0100276A2 (hu)	2002-05-29
AU9193398A (en)	1999-04-05
EP1025096A1 (fr)	2000-08-09
EE200000144A (et)	2001-02-15
JP4002392B2 (ja)	2007-10-31
KR20010024078A (ko)	2001-03-26
US6384225B1 (en)	2002-05-07

Publication	Publication Date	Title
EG24081A (en)	2008-05-11	4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
PL334847A1 (en)	2000-03-27	Substituted 3-heterocyclyl-benzoyl derivatives
GB9702194D0 (en)	1997-03-26	Sulphonide derivatives
HUP0003642A3 (en)	2001-11-28	N-alkanoylphenylalanine derivatives
ZA987602B (en)	1999-05-04	N-alkanoylphenylalanine derivatives
ZA987813B (en)	1999-03-18	Substituted chroman derivatives
IL139808A0 (en)	2002-02-10	Novel benzopyran or thiobenzopyran derivatives
HUP9801168A3 (en)	1999-11-29	Triazinylaminostilbene derivatives
IL135074A0 (en)	2001-05-20	Substituted chroman derivatives
HUP9902456A3 (en)	2002-04-29	Chroman derivatives
PL348191A1 (en)	2002-05-06	Chroman derivatives
GB2321457B (en)	2001-02-28	5-Aroylnaphthalene derivatives
NZ329788A (en)	1999-06-29	4-sulphonamide-substituted chromans
IL132982A0 (en)	2001-03-19	Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en)	1997-10-01	Amidino-camptothecin derivatives
IL133123A0 (en)	2001-03-19	Substituted cyclobutylamine derivatives
GB9725541D0 (en)	1998-02-04	Amino-benzothiazole derivatives
ZA98611B (en)	1998-08-17	Imino-aza-anthracyclinone derivatives
ZA983116B (en)	1998-10-21	Arylsecocholadiene derivatives
ZA983168B (en)	1998-10-20	New naphthylpiperazine derivatives
ZA983370B (en)	1998-10-23	Chroman derivatives
IL131159A0 (en)	2001-01-28	4-Aminoethoxyindazole derivatives
GB9706753D0 (en)	1997-05-21	Aralkoxy-morphinan derivatives
SI1005445T1 (en)	2004-12-31	N-alkanoylphenylalanine derivatives
ZA951962B (en)	1996-03-12	Chromene derivatives